A cross-sectional study examining wearable device use in cardiovascular patients revealed significant disparities influenced by demographic and socioeconomic factors. The study highlights lower adoption rates among patients with cardiovascular disease and emphasizes the importance of addressing these disparities to achieve equitable healthcare outcomes.
Read More
The American College of Cardiology (ACC) has joined forces with the National Football League’s Smart Heart Sports Coalition to support a bill in Ohio that aims to mandate the installation of Automated External Defibrillators (AEDs) and emergency action plans in schools. The legislation, if enacted, will enhance cardiac arrest prevention measures in Ohio, following similar steps taken by other states.
Read MoreA new scientific statement from the American Heart Association sheds light on the alarming disparities in peripheral artery disease prevalence and outcomes among Black adults compared to Hispanic and white adults.
Read More
Resistant hypertension poses a significant challenge for clinicians, but new pharmacologic and device-based approaches offer hope for effective and safe treatment. This article explores the diagnosis of resistant hypertension, ruling out other conditions, and innovative therapies that show promise in managing elevated blood pressure.
Read More
New evidence suggests that direct oral anticoagulants (DOACs) are safe and effective for stroke prevention in high-risk populations with atrial fibrillation. Elderly patients and those with chronic kidney disease can benefit from DOACs without increased bleeding risk. However, patients with rheumatic heart disease still require vitamin K antagonists based on recent trial results.
Read More